
Sign up to save your podcasts
Or


On today’s debut interview with Truvian Health, CEO Jay Srinivasan lays out the company’s bold but grounded plan to radically decentralize blood testing. With over $150 million raised and a benchtop instrument already in FDA review, Truvian aims to run 34 lab-quality tests from just eight drops of blood—in under 30 minutes.
“Why does your blood have to t…
By Theral Timpson4.5
3131 ratings
On today’s debut interview with Truvian Health, CEO Jay Srinivasan lays out the company’s bold but grounded plan to radically decentralize blood testing. With over $150 million raised and a benchtop instrument already in FDA review, Truvian aims to run 34 lab-quality tests from just eight drops of blood—in under 30 minutes.
“Why does your blood have to t…

32,130 Listeners

16,085 Listeners

26,398 Listeners

9,516 Listeners

1,085 Listeners

124 Listeners

12,203 Listeners

6,059 Listeners

5,478 Listeners

86 Listeners

34 Listeners

90 Listeners

145 Listeners

15,942 Listeners

96 Listeners